AKT1 and cardiac hypertrophy: As an angiogenesis inhibitor, Mindin overexpression significantly attenuates cardiac hypertrophy, left ventricular dysfunction, and myocardial fibrosis, which is partly attributed to the further activation of GSK-3β by blocking AKT in a neonatal rat model of cardiac hypertrophy 34.